Trial Profile
Phase III trial of peramivir in children and adolescents with influenza virus infections.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2010
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Shionogi
- 03 Feb 2010 Status changed from recruiting to completed as reported in a Shinogi media release.
- 26 Nov 2009 New trial record.